Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for pediatric non-cardiac chest pain
IRCT20191208045655N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in non-cardiac chest pain (NCCP) comparing Omeprazole with Control / placebo (2 arms). Primary endpoint: Severity of pain. Started Dec 2018; status: completed.
02
Drugs
omeprazole
03
Conditions
non-cardiac chest pain (NCCP)
Beyond the preview
Go deeper on IRCT20191208045655N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191208045655N1.